Affibody-based hBCMA x CD16 dual engagers for NK cell-mediated killing of multiple myeloma cells.
Giang KA, Boxaspen T, Diao Y, Nilvebrant J, Kosugi-Kanaya M, Kanaya M, Krokeide SZ, Lehmann F, Svensson Gelius S, Malmberg KJ, Nygren PÅ.
Giang KA, et al. Among authors: diao y.
N Biotechnol. 2023 Nov 25;77:139-148. doi: 10.1016/j.nbt.2023.09.002. Epub 2023 Sep 4.
N Biotechnol. 2023.
PMID: 37673373
Free article.